Showing results (31-40 of 1,069) with videos related to

Sort By:
Pageof 107
Therapeutic Advances in Neurological Disorders|May 20, 2020
Response to eculizumab in patients with myasthenia gravis recently treated with chronic IVIg: a subgroup analysis of REGAIN and its open-label extension studySaiju Jacob, Hiroyuki Murai, Kimiaki Utsugisawa, et al.
Therapeutic Advances in Neurological Disorders|May 20, 2020
Safety and efficacy of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis: 9 years' follow-up of DEFINE, CONFIRM, and ENDORSERalf Gold, Douglas L Arnold, Amit Bar-Or, et al.
Therapeutic Advances in Neurological Disorders|August 2, 2021
Diagnosing small fiber neuropathy in clinical practice: a deep phenotyping studyNadine Egenolf, Caren Meyer Zu Altenschildesche, Luisa Kreß, et al.
Therapeutic Advances in Neurological Disorders|May 26, 2021
A window into the future? MRI for evaluation of neuromyelitis optica spectrum disorder throughout the disease courseJacqueline M Solomon, Friedemann Paul, Claudia Chien, et al.
Therapeutic Advances in Neurological Disorders|August 11, 2021
Progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome in seven patients with sarcoidosis: a critical discussion of treatment and prognosisMaike F Dohrn, Gisa Ellrichmann, Rastislav Pjontek, et al.
Therapeutic Advances in Neurological Disorders|November 18, 2021
Surgical outcome and prognostic factors in spinal cord ependymoma: a single-center, long-term follow-up studyOliver Gembruch, Mehdi Chihi, Merle Haarmann, et al.
Therapeutic Advances in Neurological Disorders|November 29, 2021
The German Multiple Sclerosis and Pregnancy Registry: rationale, objective, design, and first resultsSandra Thiel, Andrea I Ciplea, Ralf Gold, et al.
Therapeutic Advances in Neurological Disorders|December 13, 2021
Anti-GFAP-antibody positive postinfectious acute cerebellar ataxia and myoclonus after COVID-19: a case reportLivia Asan, Stephan Klebe, Christoph Kleinschnitz, et al.
Therapeutic Advances in Neurological Disorders|December 24, 2021
Adverse events of rituximab in neuromyelitis optica spectrum disorder: a systematic review and meta-analysisHao Wang, Juanping Zhou, Yi Li, et al.
Therapeutic Advances in Neurological Disorders|October 13, 2022
Alemtuzumab-induced alopecia universalis and transient accommodation spasm in a patient with multiple sclerosisDimitrios Tzanetakos, Marianthi Breza, John S Tzartos, et al.
Pageof 107